Impact of Parabacteroides distasonis colonization on host microbiome, metabolome, immunity, and diabetes onset
Type 1 diabetes (T1D) is caused by autoimmune destruction of pancreatic β-cells. The insulin B-chain 9-23 (insB9-23) peptide is a critical epitope in triggering T1D. In our previous study, we showed that Parabacteroides distasonis, a human gut commensal, contains an insB9-23 mimic in its hprt protein (residues 4-18). This mimic (hprt4-18) peptide activates insB9-23-specific T cells, and P. distasonis colonization enhanced diabetes in NOD mice. However, the impact of the P. distasonis colonization on inflammation, gut microbiome, intestinal immune cells, gut permeability, cytokine, and serum metabolome profiles remained unknown. Here, we investigated these effects using specific pathogen-free (SPF) and germ-free (GF) female NOD mice. P. distasonis colonization minimally impacted gut microbiome composition, altering only 28 ASVs. In P. distasonis-colonized mice, there was a reduction in T-helper, T-effector, and B-cell populations in the intraepithelial lymphocytes, indicating a potential decrease in immune activation. Furthermore, P. distasonis colonization did not alter serum metabolome and circulating cytokine profiles (except for a decrease in IL-15) and gut permeability gene expressions. P. distasonis colonization in GF NOD mice induced severe insulitis without affecting gut permeability. Interestingly, mice gavaged with heat-inactivated (HI) P. distasonis did not affect insulitis scores or immune cell composition. These findings support our hypothesis that P. distasonis functions as a gut commensal, exerting no effect on the gut microbiome, metabolome, gut permeability, intestinal immune cell composition, or nonspecific immune activation. Instead, P. distasonis appears to trigger an insB9-23-specific immune response, potentially accelerating T1D onset in NOD mice through molecular mimicry.
Authors
- Umesh Kumar Gautam (ORCID: https://orcid.org/0000-0002-7490-2539)
- Michael A. Kiebish (ORCID: https://orcid.org/0000-0002-5678-0072)
- Dagmar Šrůtková (ORCID: https://orcid.org/0000-0003-0054-5396)
- Alessandro Pezzella (ORCID: https://orcid.org/0000-0001-6925-922X)
- Keiichiro Mine (ORCID: https://orcid.org/0000-0001-9759-4148)
- Lenoraj . Rhodes
- Kiran Kumar Girdhar (ORCID: https://orcid.org/0000-0002-5622-042X)
- Brady James
- Tomáš Hudcovic (ORCID: https://orcid.org/0000-0002-5320-4504)
- Emrah Altındiş (ORCID: https://orcid.org/0000-0001-9657-7602)
- Juan J. Aristizabal‐Henao (ORCID: https://orcid.org/0000-0002-2085-2396)
- Dogus Dogru
- Audrey Randall (ORCID: https://orcid.org/0000-0003-4587-3190)
- C.J. Howard
Institutions
- Boston College (US)
- Medical College of Wisconsin (US)
- CCL Industries (United States) (US)
- International Data Group (United States) (US)
- Czech Academy of Sciences, Institute of Microbiology (CZ)
- Framingham State University (US)
Publication Details
- Journal
- Journal of Molecular Endocrinology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1530/jme-25-0025
- Citations
- 2
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 1.61